7-Bromo-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline

Catalog No. :
ACVSUB915
CAS No. :
2377607-16-2
Molecular Formula :
C15H17BBrNO2
Molecular Weight :
334.02

IUPAC Name:7-bromo-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline

7-Bromo-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$389.00Login to see priceInquiryInquiry
250mg95%$641.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Bromo-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline
IUPAC Name7-bromo-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline
MDL No.MFCD31726480
Molecular FormulaC15H17BBrNO2
Molecular Weight334.02
SMILESCC1(C)OB(C2=CC3=CC=C(Br)C=C3N=C2)OC1(C)C
InChI KeyFSOSOBUSDDSGHS-UHFFFAOYSA-N
Synonym7-bromo-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;Quinoline, 7-bromo-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.2377607-16-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVSUB915 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACVSUB915 route product structure diagram
    ACVSUB9152377607-16-2
Inquiry

2. ACVSUB915 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRELT503 route compound structure diagram
    ACRELT5031416440-61-3 In Stock
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACVSUB915 route product structure diagram
    ACVSUB9152377607-16-2
Inquiry

Comments (0)